Aeglea BioTherapeutics (NASDAQ:AGLE) reported its Q4 earnings results on Tuesday, March 8, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as innovative solutions for rare metabolic diseases,